Search clinical trials for: dulanermin

Total 6 results

Shanghai Gebaide Biotechnology Co., Ltd.

Unknown

A Phase III Trial of Recombinant Human Apo-2 Ligand for Injection

Non-small-cell Lung Cancer (NSCLC) Stage IV

China
University of Alabama at Birmingham
National Institutes of Health (NIH); Fogarty International Center of the National...

Active, not recruiting

Liver Fibrosis in Zambian HIV-HBV Co-infected Patients

Hepatocellular Carcinoma | Fibrosis, Liver | HBV | Cirrhosis, Liver | Human Immunodeficiency Virus | Alcoholic Hepatitis | Hepatitis Delta Virus

Zambia
Genentech, Inc.
Amgen

Terminated

A Study of Dulanermin in Combination With Rituximab in Subjects With Follicular and Other Low Grade, CD20+, Non-Hodgkin's Lymphomas

Non-Hodgkin's Lymphoma
Genentech, Inc.

Completed

A Study of Dulanermin Administered in Combination With the FOLFOX Regimen and Bevacizumab in Patients With Previously Untreated, Locally Advanced, Recurrent, or Metastatic Colorectal Cancer

Metastatic Colorectal Cancer

United States
Genentech, Inc.

Completed

A Study of Dulanermin Administered in Combination With Camptosar®/Erbitux® Chemotherapy or FOLFIRI (With or Without Bevacizumab) in Subjects With Previously Treated Metastatic Colorectal Cancer

Colorectal Cancer

United States
Amgen
Genentech, Inc.

Completed

A Study of AMG 951 [rhApo2L/TRAIL] in Subjects With Previously Untreated Non-Small Cell Lung Cancer (NSCLC) Treated With Chemotherapy +/- Bevacizumab

Non-Small Cell Lung Cancer

3

Subscribe